Figure 4.
Mutations detected at baseline and at relapse in patients who relapsed on gilteritinib.

Mutations detected at baseline and at relapse in patients who relapsed on gilteritinib.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal